Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathwaysIoannis K. Zervantonakis, Joan S. Brugge, Matthew D. Poskus et al.|Proceedings of the National Academy of Sciences|2020Cited by 33